It is worth noting that the co‐mutation of SETD2 and SMAD4 predicted advanced CRC in The Cancer Genome Atlas (TCGA) database, and little is known on the potential synergistic effect of SETD2 and SMAD4. This evidence concerns the gene SMAD4 and colorectal carcinoma.